SLNSW-Cetuximab, gemcitabine, and oxaliplatin in patien...-TN_cdi_proquest_journals_816191057

Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study

Full title: Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study

Author/creator: Gruenberger, Birgit, Dr, Schueller, Johannes, MD, Heubrandtner, Ute, MPharm, Wrba, Fritz, MD, Tamandl, Dietmar, MD, Kaczirek, Klaus, MD, Roka, Rudolf, MD, Freimann-Pircher, Sandra, MPharm, Gruenberger, Thomas, MD.

Call Numbers:

Record Identifier: TN_cdi_proquest_journals_816191057

Language: English

Formats: Articles

Publishers: England: Elsevier Ltd

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_816191057

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study

    Record identifier

    TN_cdi_proquest_journals_816191057

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_816191057

    Share

    Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_816191057

    Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study

    Full title

    Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study

    Author / Creator

    Gruenberger, Birgit, Dr ; Schueller, Johannes, MD ; Heubrandtner, Ute, MPharm ; Wrba, Fritz, MD ; Tamandl, Dietmar, MD ; Kaczirek, Klaus, MD ; Roka, Rudolf, MD ; Freimann-Pircher, Sandra, MPharm ; Gruenberger, Thomas, MD

    Publisher

    England: Elsevier Ltd

    Journal title

    The lancet oncology, 2010, Vol.11 (12), p.1142-1148

    Record Identifier

    TN_cdi_proquest_journals_816191057

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Aged Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized Antimitotic agents Antineoplastic agents Antineoplastic Agents - therapeutic use Antineoplastic Combined Chemotherapy Protocols Biliary Tract Neoplasms - drug therapy Biliary Tract Neoplasms - genetics Biliary Tract Neoplasms - mortality Cancer Care and treatment Cetuximab Chemotherapy Cholangiocarcinoma - drug therapy Cholangiocarcinoma - genetics Cholangiocarcinoma - mortality Deoxycytidine - analogs & derivatives Deoxycytidine - therapeutic use Female Hematology, Oncology and Palliative Medicine Humans Kaplan-Meier Estimate Male Metastasis Middle Aged Mutation Neoplasm Staging Oncology, Experimental Organoplatinum Compounds - therapeutic use Proto-Oncogene Proteins - genetics Proto-Oncogene Proteins p21(ras) ras Proteins - genetics

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_proquest_journals_816191057

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_816191057

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections